(Q75307151)

English

A dose-escalating pilot study of sterically stabilized, pegylated liposomal doxorubicin (Lipo-Dox) in patients with metastatic breast cancer

scientific article published on 01 January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

A dose-escalating pilot study of sterically stabilized, pegylated liposomal doxorubicin (Lipo-Dox) in patients with metastatic breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ta-Chung Chao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Wei-Shu Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Chueh-Chuan Yen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Tzeon-Jye Chiou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Jin-Hwang Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Po-Min Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

837-847

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Adjuvant chemotherapy for breast cancer: an update.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Safety aspects of pegylated liposomal doxorubicin in patients with cancer.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120025086

21 January 2018

Identifiers

10.1081/CNV-120025086

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14735687%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q75307151&oldid=2086887827"